The Drug-Induced Respiratory Disease Website and App

Corticosteroids, systemic (oral, parenteral)

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

LIX.c

Aspergillosis, pulmonary (invasive, allergic [ABPA], or mycetoma)

Publications

Kurosaki F, Bando M, Nakayama M, Mato N, Nakaya T, Yamasawa H, Yoshimoto T, Fukushima N, Sugiyama Y

Clinical features of pulmonary aspergillosis associated with interstitial pneumonia.

Internal medicine (Tokyo, Japan) 2014;53;1299-306 — 2014 — 1299-306

Montagna MT, Lovero G, Coretti C, Martinelli D, Delia M, De Giglio O, Caira M, Puntillo F, D'Antonio D, Venditti M, Sambri V, Di Bernardo F, Barbui A, Lo Cascio G, Concia E, Mikulska M, Viscoli C, Maximova N, Candoni A, Oliveri S, Lombardi G, Pitzurra L,

SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients.

Infection 2014 Feb;42;141-51 — 2014 Feb — 141-51

Wessolossky M, Welch VL, Sen A, Babu TM, Luke DR

Invasive Aspergillus infections in hospitalized patients with chronic lung disease.

Infection and drug resistance 2013;6;33-9 — 2013 — 33-9

Tunnicliffe G, Schomberg L, Walsh S, Tinwell B, Harrison T, Chua F

Airway and parenchymal manifestations of pulmonary aspergillosis.

Respiratory medicine 2013 Aug;107;1113-23 — 2013 Aug — 1113-23

Choi YR, Kim JT, Kim JE, Jung HW, Choe KH, Lee KM, An JY

Invasive aspergillosis involving the lungs and brain after short period of steroid injection: a case report.

Tuberculosis and respiratory diseases 2012 May;72;448-51 — 2012 May — 448-51

Fernández-Ruiz M, Silva JT, San-Juan R, de Dios B, García-Luján R, López-Medrano F, Lizasoain M, Aguado JM

Aspergillus tracheobronchitis: report of 8 cases and review of the literature.

Medicine 2012 Sep;91;261-73 — 2012 Sep — 261-73

Papadopoulos A, Ntaios G, Kaiafa G, Girtovitis F, Charisopoulos G, Chryssogonidis I

Fatal pulmonary and cerebral aspergillosis after a short course of corticosteroids for idiopathic thrombocytopenic purpura.

Annals of hematology 2008 Aug;87;685-6 — 2008 Aug — 685-6

Chong S, Lee KS, Yi CA, Chung MJ, Kim TS, Han J

Pulmonary fungal infection: imaging findings in immunocompetent and immunocompromised patients.

European journal of radiology 2006 Sep;59;371-83 — 2006 Sep — 371-83

Cornet M, Mallat H, Somme D, Guérot E, Kac G, Mainardi JL, Fornes P, Gutmann L, Lavarde V

Fulminant invasive pulmonary aspergillosis in immunocompetent patients--a two-case report.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2003 Dec;9;1224-7 — 2003 Dec — 1224-7

Rello J, Esandi ME, Mariscal D, Gallego M, Domingo C, Valles J

Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998 Jun;26;1473-5 — 1998 Jun — 1473-5

Palmer LB, Greenberg HE, Schiff MJ

Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease.

Thorax 1991 Jan;46;15-20 — 1991 Jan — 15-20